TY - JOUR
T1 - In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed
AU - Bonanini, Flavio
AU - Kurek, Dorota
AU - Previdi, Sara
AU - Nicolas, Arnaud
AU - Hendriks, Delilah
AU - de Ruiter, Sander
AU - Meyer, Marine
AU - Clapés Cabrer, Maria
AU - Dinkelberg, Roelof
AU - García, Silvia Bonilla
AU - Kramer, Bart
AU - Olivier, Thomas
AU - Hu, Huili
AU - López-Iglesias, Carmen
AU - Schavemaker, Frederik
AU - Walinga, Erik
AU - Dutta, Devanjali
AU - Queiroz, Karla
AU - Domansky, Karel
AU - Ronden, Bob
AU - Joore, Jos
AU - Lanz, Henriette L.
AU - Peters, Peter J.
AU - Trietsch, Sebastiaan J.
AU - Clevers, Hans
AU - Vulto, Paul
N1 - Funding Information:
We would like to thank Rumaisha Annida and members of the Microscopy CORE Lab of M4I-FHML of Maastricht University for their technical support and Kristin Bircsak for valuable comments. We also would like to thank Mimetas Biocore team including Kristina Bishard, Arthur Stok, Manon Haarmans, and Julia Grasegger This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 848429 and Interreg, project Biomat on microfluidic chip 433. AN and FB have received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 641639 and No 812616, respectively. This project was partly funded by an innovation loan (IK17088) from the Dutch Ministry of Economic Affairs and Climate. This work was supported by partners of Regenerative Medicine Crossing Borders (www.regmedxb.com), powered by Health-Holland, Top Sector Life Sciences & Health.
Funding Information:
We would like to thank Rumaisha Annida and members of the Microscopy CORE Lab of M4I-FHML of Maastricht University for their technical support and Kristin Bircsak for valuable comments. We also would like to thank Mimetas Biocore team including Kristina Bishard, Arthur Stok, Manon Haarmans, and Julia Grasegger This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 848429 and Interreg, project Biomat on microfluidic chip 433. AN and FB have received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 641639 and No 812616, respectively. This project was partly funded by an innovation loan (IK17088) from the Dutch Ministry of Economic Affairs and Climate. This work was supported by partners of Regenerative Medicine Crossing Borders (www.regmedxb.com), powered by Health-Holland, Top Sector Life Sciences & Health.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/11
Y1 - 2022/11
N2 - With recent progress in modeling liver organogenesis and regeneration, the lack of vasculature is becoming the bottleneck in progressing our ability to model human hepatic tissues in vitro. Here, we introduce a platform for routine grafting of liver and other tissues on an in vitro grown microvascular bed. The platform consists of 64 microfluidic chips patterned underneath a 384-well microtiter plate. Each chip allows the formation of a microvascular bed between two main lateral vessels by inducing angiogenesis. Chips consist of an open-top microfluidic chamber, which enables addition of a target tissue by manual or robotic pipetting. Upon grafting a liver microtissue, the microvascular bed undergoes anastomosis, resulting in a stable, perfusable vascular network. Interactions with vasculature were found in spheroids and organoids upon 7 days of co-culture with space of Disse-like architecture in between hepatocytes and endothelium. Veno-occlusive disease was induced by azathioprine exposure, leading to impeded perfusion of the vascularized spheroid. The platform holds the potential to replace animals with an in vitro alternative for routine grafting of spheroids, organoids, or (patient-derived) explants.
AB - With recent progress in modeling liver organogenesis and regeneration, the lack of vasculature is becoming the bottleneck in progressing our ability to model human hepatic tissues in vitro. Here, we introduce a platform for routine grafting of liver and other tissues on an in vitro grown microvascular bed. The platform consists of 64 microfluidic chips patterned underneath a 384-well microtiter plate. Each chip allows the formation of a microvascular bed between two main lateral vessels by inducing angiogenesis. Chips consist of an open-top microfluidic chamber, which enables addition of a target tissue by manual or robotic pipetting. Upon grafting a liver microtissue, the microvascular bed undergoes anastomosis, resulting in a stable, perfusable vascular network. Interactions with vasculature were found in spheroids and organoids upon 7 days of co-culture with space of Disse-like architecture in between hepatocytes and endothelium. Veno-occlusive disease was induced by azathioprine exposure, leading to impeded perfusion of the vascularized spheroid. The platform holds the potential to replace animals with an in vitro alternative for routine grafting of spheroids, organoids, or (patient-derived) explants.
KW - In vitro grafting
KW - Liver organoids and spheroids
KW - Microfluidics
KW - Vascularization
UR - https://www.scopus.com/pages/publications/85132114484
U2 - 10.1007/s10456-022-09842-9
DO - 10.1007/s10456-022-09842-9
M3 - Article
C2 - 35704148
AN - SCOPUS:85132114484
SN - 0969-6970
VL - 25
SP - 455
EP - 470
JO - Angiogenesis
JF - Angiogenesis
IS - 4
ER -